Rassegna stampa #32 del 10 settembre Giulio D'Alfonso 11 Settembre 2020 1101 Questa è la copia della ultima newsletter inviata. Se non ti è arrivata clicca...
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial Redazione 10 Settembre 2020 ...
Outcomes of COVID-19 in patients with CLL: a multicenter international experience Redazione 10 Settembre 2020 ...
Ponatinib coronary microangiopathy: novel bedside diagnostic approach and management with N-acetylcysteine Redazione 10 Settembre 2020 ...
US Food and Drug Administration approvals for Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukemia: Potential inefficiencies in trial design and evidence generation Redazione 10 Settembre 2020 ...
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study Redazione 10 Settembre 2020 ...
Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population Redazione 3 Settembre 2020 ...
Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells Redazione 3 Settembre 2020 ...